BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 25256370)

  • 1. Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension.
    Kawanaka H; Akahoshi T; Itoh S; Iguchi T; Harimoto N; Uchiyama H; Yoshizumi T; Shirabe K; Takenaka K; Maehara Y
    J Am Coll Surg; 2014 Nov; 219(5):865-74. PubMed ID: 25256370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portal vein thrombosis treated using danaparoid sodium and antithrombin III.
    Uchiyama T; Hirokazu T; Hosono K; Endo H; Akiyama T; Yoneda K; Inamori M; Abe Y; Kubota K; Saito S; Nakajima A
    Hepatogastroenterology; 2010; 57(97):52-3. PubMed ID: 20422871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism.
    Kawanaka H; Akahoshi T; Kinjo N; Konishi K; Yoshida D; Anegawa G; Yamaguchi S; Uehara H; Hashimoto N; Tsutsumi N; Tomikawa M; Maehara Y
    Ann Surg; 2010 Jan; 251(1):76-83. PubMed ID: 19864937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
    Hayashi T; Takatori H; Horii R; Nio K; Terashima T; Iida N; Kitahara M; Shimakami T; Arai K; Kitamura K; Kawaguchi K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Toyama T; Okumura K; Kozaka K; Kaneko S
    BMC Gastroenterol; 2019 Dec; 19(1):217. PubMed ID: 31842768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension.
    Kinjo N; Kawanaka H; Akahoshi T; Tomikawa M; Yamashita N; Konishi K; Tanoue K; Shirabe K; Hashizume M; Maehara Y
    Br J Surg; 2010 Jun; 97(6):910-6. PubMed ID: 20474001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preoperative risk factors of portal venous thrombosis after splenectomy and gastric pericardial devascularization for portal hypertension].
    Han J; Yi Y; Ding H; Liu J; Zhang Y; Hu L; Zhao L; Liu T
    Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):739-43. PubMed ID: 25496862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment by danaparoid sodium for portal venous thrombosis].
    Shudo R; Yazaki Y; Sugawara K; Honda M
    Nihon Shokakibyo Gakkai Zasshi; 2007 Feb; 104(2):205-12. PubMed ID: 17283415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early prophylactic anticoagulation via transjugular intrahepatic route for portal vein thrombosis after splenectomy in cirrhotic portal hypertension.
    Yang S; He C; Fan X; Ding W; Wu X; Li J
    J Vasc Interv Radiol; 2015 Jul; 26(7):1009-17. PubMed ID: 25921970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement: The Danaparoid Hip Arthroplasty Investigators Group.
    Comp PC; Voegeli T; McCutchen JW; Skoutakis VA; Trowbridge A; Overdyke WL
    Orthopedics; 1998 Oct; 21(10):1123-8. PubMed ID: 9801236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Portal vein flow rate used as a early predictor of portal vein thrombosis after periesophagastric devascularization].
    Zhang Y; Wen TF; Chen ZY; Yan LN; Liang GL; Li G; Zhang XH; Ran S; Liao ZX
    Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(11):825-8. PubMed ID: 19961011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful use of danaparoid in the treatment of portal vein thrombosis that developed in a warfarin-administered hepatitis C virus-related cirrhosis patient].
    Nawata Y; Hamada K; Tajima H; Nishino N; Nakazawa T; Tobayashi K; Saitoh S
    Nihon Shokakibyo Gakkai Zasshi; 2012 Aug; 109(8):1394-400. PubMed ID: 22863964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative Anticoagulants in Preventing Portal Vein Thrombosis in Patients Undergoing Splenectomy Because of Liver Cirrhosis: A Meta-Analysis.
    Zhang JY; Wang YB; Gong JP; Zhang F; Zhao Y
    Am Surg; 2016 Dec; 82(12):1169-1177. PubMed ID: 28234180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Era of liver transplantation: combined anatomic splenectomy and anticoagulant therapy in prevention of portal vein thrombosis after splenectomy.
    Hongwei C; Zhang L; Maoping L; Yong Z; Chengyou D; Dewei L
    Hepatogastroenterology; 2015; 62(138):405-9. PubMed ID: 25916072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal Vein Thrombosis After Splenic and Pancreatic Surgery.
    Ruiz-Tovar J; Priego P
    Adv Exp Med Biol; 2017; 906():241-251. PubMed ID: 27638624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of preoperative portal vein thrombosis after administration of antithrombin III in living donor liver transplantation: case report.
    Imai H; Egawa H; Kajiwara M; Nakajima A; Ogura Y; Hatano E; Ueda M; Kawaguchi Y; Kaido T; Takada Y; Uemoto S
    Transplant Proc; 2009 Nov; 41(9):3931-3. PubMed ID: 19917415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors of Portal Vein Thrombosis after Devascularization Treatment in Patients with Liver Cirrhosis: A Nested Case-Control Study.
    Lu S; Hu G; Chen S; Wang J
    Biomed Res Int; 2020; 2020():9583706. PubMed ID: 32908928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal vein thrombosis after splenectomy in pediatric hematologic disease: risk factors, clinical features, and outcome.
    Soyer T; Ciftci AO; Tanyel FC; Senocak ME; Büyükpamukçu N
    J Pediatr Surg; 2006 Nov; 41(11):1899-902. PubMed ID: 17101367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal vein thrombosis after splenectomy for gastric malignant lymphoma.
    Fujitani K; Nishiyama A; Tsujinaka T; Hirao M; Hasuike Y; Takeda Y
    Gastric Cancer; 2003; 6(4):250-4. PubMed ID: 14716520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.